Related Experiment Video
Updated: Jan 22, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Pearls and pitfalls in the diagnosis and management of mitral annular calcification
Sebastiaan Dhont1,2,3, Gitte P H van den Acker3, Timothy W Churchill4
1Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Insights
Mitral annular calcification (MAC) is a growing cause of mitral stenosis, impacting heart function and increasing cardiovascular risk. Early diagnosis and management are key, prioritizing medical therapy and specialized interventions for severe cases.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Biomedical Engineering
Background:
- Mitral annular calcification (MAC) is a progressive degenerative condition with significant clinical implications.
- MAC is now the leading cause of mitral stenosis in developed nations, surpassing rheumatic heart disease.
- It contributes to mitral valve dysfunction, arrhythmias, systemic embolization, and increased cardiovascular risk.
Purpose of the Study:
- To review the clinical impact, pathophysiology, diagnosis, and management of MAC.
- To highlight the challenges in diagnosing MAC-related valve dysfunction and the importance of multimodality imaging.
- To discuss current management strategies and potential future therapeutic advances.
Main Methods:
- Literature review of studies on MAC, focusing on pathophysiology, diagnosis, and management.
- Analysis of diagnostic challenges and the role of advanced imaging techniques like 3D echocardiography and cardiac CT.
- Evaluation of current treatment approaches, including medical therapy and interventional procedures.
Main Results:
- MAC pathophysiology involves mechanical stress, inflammation, and osteogenic differentiation, accelerated by age, CKD, and metabolic issues.
- Traditional echocardiography is often unreliable for diagnosing MAC-related dysfunction; multimodality imaging is crucial.
- Symptoms may stem from combined valvular and myocardial disease, requiring careful hemodynamic assessment.
Conclusions:
- Management of MAC should prioritize medical therapy for symptoms and comorbidities like HFpEF.
- Interventional approaches (surgical, transcatheter) are high-risk and reserved for selected patients in specialized centers.
- Future research may focus on therapies targeting calcification pathways and tailored devices.
Abstract:
Mitral annular calcification (MAC) is a progressive, degenerative process increasingly recognised for its clinical impact. Beyond being an incidental finding, MAC contributes to mitral valve dysfunction, arrhythmias, systemic embolisation and elevated cardiovascular risk. In developed countries, it has now overtaken rheumatic disease as the leading cause of mitral stenosis.The pathophysiology of MAC involves chronic mechanical stress, pro-inflammatory activation and osteogenic differentiation of valvular cells. Progression is accelerated by age, chronic kidney disease and metabolic derangements. Diagnosing MAC-related valve dysfunction is challenging, as traditional echocardiographic measures often prove unreliable. Multimodality imaging-including 3D echocardiography and cardiac CT-is essential for assessing anatomy, function and procedural feasibility. Importantly, symptoms often reflect combined valvular (eg, aortic stenosis) and myocardial disease (eg, heart failure with preserved ejection fraction (HFpEF) phenocopy), necessitating careful haemodynamic evaluation to avoid futile interventions.Management should prioritise medical therapy for symptom control and comorbid HFpEF, reserving interventions for selected patients. Surgical and transcatheter approaches carry high risk and should be undertaken only in specialised centres. Future advances may include tailored devices and therapies targeting calcification pathways.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Valve Prolapse III: Nursing Management

